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Complications of 
Treated Cushing's Syndrome 
Lewis B. Mor row, M D , * Raymond C. Mel l inger, M D , * * 
M . Saeed Zafar, M D * * and Richmond W. Smith, Jr., MD* 
Fifty-two patients with Cushing's syndrome 
are reported with emphasis on post treatment 
complications. Seven patients, cured of their 
disease following appropriate therapy, had a 
recurrence of adrenal hypersecretion from 
one to ten years later. This occurred after all 
modalities of treatment, but was more com-
mon after sub-total adrenalectomy. Pituitary 
adenomas were found in two cases. 
Pseudotumor cerebri, psychiatnc complica-
tions, hyperthyroidism and hyperpigmenta-
tion were observed. One patient developed 
progressive hyperplgmentation despite pitui-
tary radiation. Thirteen of fifty-two patients 
had malignant disease including three 
endometrial carcinomas, one rectal car-
cinoma and one adenocarcinoma ofthe man-
dible. Despite the remarkable improvement 
In the prognosis for patients with Cushing's 
syndrome, this population continues to be at 
high risk for late complications and warrants 
close follow-up medical care. 
'Division of Endocrinology, Department of 
Medicine, Highland Hospital, University of 
Rochester, School of Medicine, Rochester, 
NY (formerly of Henry Ford Hospital) 
•'Division of Endocrinology, Department of 
Medicine 
Address reprint requests to Dr. Morrow at 
920 Highland Ave., Rochester, NY 14620 
I N 1952, Plotz and co-workers re-
p o r t e d a 50% f ive-year m o r t a l i t y in 
patients treated for Cushing's syn-
drome. ' As therapeutic modalit ies were 
r e f i n e d , unders tand ing of the disease 
advanced by soph i s t i ca ted s t e ro i d 
assays and adrenal replacement therapy 
widely used, the out look for the patient 
w i t h Cush ing ' s s y n d r o m e i m p r o v e d 
progressively. A 1971 review describing 
108 patients w i t h Cushing 's syndrome 
documented this dramatic improve-
ment.^ Wi th the exception of adrenal or 
ACTH producing malignancies, present 
therapy is now cons idered curat ive in 
most instances. Nevertheless, late and 
serious complications are still reported 
in t rea ted pa t ien ts . ^ ' " We report 
here our experience w i th 52 patients 
w i t h Cush ing 's synd rome seen at the 
Hen ry Ford Hosp i ta l f r o m 1950-1970. 
Particular attention is given to the prob-
lem of recurrent Cushing's syndrome in 
patients treated and restored to a eucor-
t ical c o n d i t i o n . Case repor ts of seven 
such patients are presented in detail . In 
a d d i t i o n , o the r c o m p l i c a t i o n s w h i c h 
were encountered are discussed. 
Methods and Patients 
All patients seen f rom 1950-1970 wi th 
the diagnosis of adrenal hypercort isol-
ism are inc luded. Diagnoses were estab-
l ished using rou t ine assay procedures 
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for ur inary 17 hydroxysteroids^ and 17 
ketosteroids.' ' Responses to metyra-
pone, ACTH and dexamethasone sup-
p ress ion^ w e r e also s t u d i e d in mos t 
cases. Plasma Cort isol was measured 
rout ine ly since 1960. In a few pat ients 
the u r i na ry f ree Cor t iso l was also 
measured to conf i rm the diagnosis. 
As shown in Table 1, six patients had 
Cortisol p roduc ing adrenal adenomas, 
f o u r had adrena l c a r c i n o m a s , 39 
pa t ien ts had adrena l hyperp las ia 
(nodular hyperplasia was noted in one 
of these pat ien ts ) , and th ree pat ients 
had putat ive ectopic ACTH syndrome 
but the diagnoses were not verif ied by 
ACTH assay. There were 38 females and 
14 males ranging in age f rom 2 months 
to 71 years. Peak inc idence of disease 
o c c u r r e d in the f o u r t h decade . The 
mean f o l l o w - u p (Table I) fo r pat ients 
w i th adenomas was 14 years and w i t h 
hyperplasia 9.2 years. The patients wi th 
adrenal cancer or ectopic ACTH syn-
drome all died wi th in four years of diag-
nosis. 
Treatment 
The initial therapy employed and the 
results are shown in Table 11. For the 
purpose of this paper, a cure is def ined 
as a pe rmanen t r e d u c t i o n of Cort isol 
secretion to normal basal levels, either 
w i t h or w i t h o u t s tero id rep lacement , 
and disappearance of associated clinical 
abnormalit ies. A recurrence is diag-
nosed in those patients wi th Cushing's 
syndrome w h o achieved d o c u m e n t e d 
clinical and laboratory evidence of nor-
mal or subnormal Cortisol secretion and 
subsequen t l y deve loped c l in ica l and 
laboratory f indings of adrenal overac-
t i v i t y . Pat ients c lass i f ied as f a i l u r e s , 
a l t h o u g h usua l ly d e m o n s t r a t i n g 
i m p r o v e m e n t a f te r in i t ia l t r e a t m e n t , 
cont inued to excrete elevated glucocor-
t icoids. 
All six patients wi th adrenal adenomas 
were successfully treated w i th unilateral 
adrenalectomy and cured of their dis-
ease. Of the four patients wi th adrenal 
carcinoma, two were treated wi th surgi-
cal excision. One achieved a temporary 
s l ight ame l io ra t ion of hyperco r t i c i sm 
whi le the other was completely eucor-
t icoid for one year. His case history is 
described later. The other two patients 
were e x p l o r e d , but the i r carc inomas 
w e r e un resec tab le . A l l f o u r pa t ien ts 
were subsequently treated wi th or tho-
para' DDD wi th improvement in cir-
culating Cortisol levels. 
Sixteen of 39 pat ients w i t h adrena l 
hyperplasia underwent total adrenalec-
tomy as initial therapy and 15 of these 
were cured. The one recurrence wi l l be 
discussed. Fourteen patients received 
in i t ia l therapy w i th p i tu i tary rad iat ion. 
Six were cured. Two, whose case his-
tories are presented later, experienced 
a recurrence. Six were failures requir ing 
addit ional treatment. 
Five patients wi th adrenal hyperplasia 
were treated by unilateral adrenalec-
t o m y f o l l o w e d by p i tu i ta ry rad ia t i on . 
Two of these patients were cured, whi le 
the o t h e r t h r e e pa t ien ts r e q u i r e d 
f u r t h e r t h e r a p y . Th ree pa t ien ts w i t h 
adrenal hyperplasia were treated ini-
tially wi th subtotal adrenalectomy. One 
pat ient has done we l l w i t h o u t fu r ther 
t rea tment . Two recurred and they w i l l 
be discussed. 
Two of the three patients wi th ectopic 
ACTH were cured of their hypercort i -
cism but died of their underly ing dis-
ease w h i l e one w i t h an assoc ia ted 
pheochromocytoma died at surgery. 
Table 111 shows the t r e a t m e n t 
received by the six patients wi th persis-
t e n t disease a f te r r a d i a t i o n . Th ree 
i m m e d i a t e l y u n d e r w e n t a b i la te ra l 
adrenalectomy result ing in a permanent 
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TABLE I 
CUSHING'S SYNDROME 1950-1970 
Adrenal Diagnosis Number 
Ages Sex Follow-Up In Years 
Range Mean F M Range Mean 
Adenoma 6 32-56 42 5 1 1-19 14 
Carcinoma 4 15-45 33 1 3 0.2-4 1.2 
Hyperplasia 39 0.2-71 36 30 9 0-20 9,2 
Ectopic ACTH 3 6, 46, 59 2 1 0-4 1 
TABLE II 
PRIMARY TREATMENT 
Diagnosis Treatment Number Cure Recurrence Failure 
Adenoma Unilateral Adrenalectomy 6 6 0 0 
Carcinoma Surgery & Ortho Para' DDD 4 0 1 3 
Hyperplasia Adrenalectomy 16 15 1 0 
Radiation 14 6 2 6 
Unilateral Adrenalectomy & 
Radiation 5 2 0 3 
Subtotal Adrenalectomy 3 1 2 0 
Not treated 1 
Ectopic ACTH Adrenalectomy 3 2 0 r 
•Died at Operation 
TABLE III 
FOLLOW-UP TREATMENT OF SIX RADIATION FAILURES 
Treatment Num ber Permanent Cure Recurrence Failure 
Bilateral Adrenalectomy 3 2 1 0 
Unilateral Adrenalectomy 2 0 0 2-
Under Observation 1 
'Both cured with total adrenalectomy 
cure in two. In the third, after a 10-year 
remission, recurrent, overactive adrenal 
tissue was located by radioactive 
iodocholesterol scanning and was suc-
cessfully removed. Two of the six radia-
tion failures were subjected to unilateral 
adrenalectomy which was unsuccessful, 
necessitating a total adrenalectomy for 
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e v e n t u a l c u r e . O n e p a t i e n t is s t i l l u n d e r 
o b s e r v a t i o n . 
C u s h i n g ' s s y n d r o m e r e c u r r e d i n 
seven p a t i e n t s a f te r i n i t i a l t r e a t m e n t h a d 
r e s u l t e d i n a d o c u m e n t e d c l i n i c a l a n d 
l a b o r a t o r y c u r e . Th i s i n c i d e n c e o f o v e r 
1 3 % w a s a s i g n i f i c a n t c o m p l i c a t i o n In 
o u r se r ies . Case h i s t o r i e s o f t h e s e s e v e n 
p a t i e n t s f o l l o w . 
C a s e Repor ts 
Case # 1 . This school boy was first seen in 
D e c e m b e r o f 1967 at 12 years o f age fo r 
e v a l u a t i o n o f o b e s i t y , acne and g r o w t h 
fa i lu re . Basal 17 hydroxys te ro ids we re 17.3 
m g and 17 k e t o s t e r o i d s 15.7 mg per day . 
There was marked hyper-responsiveness to 
ACTH wi th a rise in 17 hydroxysteroids to 100 
mg per day and 17 ketosteroids to 51 mg per 
day. In Eebruary of 1968 he was treated w i th 
4,500 roen tgens to the p i tu i ta ry g land and 
t w o mon ths later basal 17 hydroxys te ro ids 
and 17 k e t o s t e r o i d s had fa l l en to no rma l 
levels of 5.5 and 7.3 mg per day, respectively. 
This was associated cl inical ly w i th a "catch-
u p g r o w t h s p u r t " as he had a 7^k i n c h 
increase in height over the next 16 months. 
In 1969 the growth rate decreased and symp-
toms of recurrent disease appeared. Evalua-
t ion in September of 1970 revealed a plasma 
Cort isol o f 17.1 m c g % w h e n c h e c k e d at 8 
a .m. w h i c h suppressed inadequate ly to 6.5 
mcg% fo l lowing 1 mg of dexamethasone. No 
a d d i t i o n a l t r e a t m e n t has b e e n g i v e n , 
al though recurrence of his disease has been 
documen ted . 
Case # 2 . This 25-year-old woman was seen 
in July 1953 for progressive weight ga in, men-
strual i r regu lar i t ies and h i r su t i sm. Basal 17 
hyd roxys te ro ids and 17 ke tos te ro ids w e r e 
19.5 and 12.1 mg per day and 17 hydroxy-
steroids rose to 56.2 mg per day w i th 20 units 
of ACTH gel over a two-day per iod . Pituitary 
radiation was administered at another hospi-
tal nearer her home in August 1953 and by 
the fall of that year complete remission had 
occurred. The radiation dose is not k n o w n ; 
17 hydroxysteroids were 3.8 mg per day and 
17 ketosteroids 4.4 mg per day. 
She had no f u r t h e r d i f f i c u l t y u n t i l 1958 
w h e n she d e v e l o p e d w e a k n e s s , f a t i g u e , 
depression and recurrent disease, veri f ied by 
l abo ra to ry t es t i ng . Plasma Cort isol was 31 
mcg% w i thou t diurnal variation and basal ur i -
nary 17 hyd roxys te ro ids w e r e 22.4 mg per 
day . In M a r c h o f 1959 a n o t h e r c o u r s e o f 
pituitary radiation was administered. By Feb-
ruary of 1960, she was a s y m p t o m a t i c and 
basal urinary 17 hydroxysteroids were 4.8 mg 
per day and 17 ketosteroids 6.8 m g per day. 
Three years later she again noted symptoms 
of hypercort ic ism and urinary 17 hydroxy-
steroids had risen to 18.9 mg per day w i th a 
urinary free Cortisol of 610 meg per 24 hours. 
A total bilateral adrenalectomy was done in 
May of 1963. She has had no fur ther d i f f icul ty 
since then and has been maintained on ful l 
r e p l a c e m e n t t h e r a p y . She has d e v e l o p e d 
p rog ress i ve h y p e r p l g m e n t a t i o n , w i t h o u t 
enlargement of the sella turcica. 
Case # 3 . In 1951, at t he age o f 34, th is 
patient had a complete resection of the left 
adrenal gland and 90% resecl ion of the right 
adrenal for Cushing's disease. Replacement 
therapy consisted of prednisone 5 mg daily 
unt i l 1959 when it was decreased to 2y2 mg 
dai ly and even tua l l y d i s c o n t i n u e d in 1960. 
When first seen at this hospital her skin was 
deep l y p i g m e n t e d and she was weak and 
cachectic. Basal 17 hydroxysteroids were 5.7 
m g and 17 k e t o s t e r o i d s 2.2 m g per day . 
Eighty units of ACTH for several days pro-
duced no increase in g lucocort icoid produc-
t i on . The diagnosis o f Addison's disease w i th 
a m a x i m a l l y s t i m u l a t e d smal l ad rena l 
remnant was conf i rmed and the patient dis-
charged w i t h 9-alpha f l u r o h y d r o c o r t i s o n e 
p resc r ibed . In 1964 signs and symptoms of 
recurrent Cushing's disease deve loped. The 
m i n e r a l o c o r t i c o i d was d i s c o n t i n u e d and 
plasma Cortisol was 9.6 mcg%, w i th no diur-
nal v a r i a t i o n . She r e m a i n e d a p p a r e n t l y 
eucortical unti l 1970 when adrenal insuff i -
ciency was again documented . Plasma Cor-
tisol was 0.5 mg%. Since that t ime the pat ient 
has required 20 mg hydrocort isone daily. The 
ad rena l r e m n a n t i n i t i a l l y a p p e a r e d to be 
insuff ic ient to maintain normal cort icoid pro-
duc t ion . Wi th t ime , the gland size probably 
en la rged in response to pe rs i s ten t ACTH 
st imulat ion and the recurrent Cushing's syn-
d r o m e resu l ted f r o m the add i t i ve e f fec t of 
exogenous and endogenous glucocort ico ids. 
The explanat ion for the adrenal fa i lure f ive 
years later is not apparent. This patient has 
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no p i tu i t a ry en la rgemen t or o t he r ev iden t 
endocr ine abnormal i ty . 
Case # 4 . This patient was 22 years o ld in 
1950 when the diagnosis of Cushing's disease 
was made and she was treated w i th a 90% left 
adrenalectomy at another hospital . She was 
first seen at Henry Ford Hospital in 1955 w i th 
symptoms of recurrent Cushing's disease. 17 
hydroxys te ro ids and 17 ke tos te ro ids w e r e 
36.7 and 36.2 mg per day and rose w i th ACTH 
to 74.6 and 59.4 mg . When r ight adrenal tis-
sue weigh ing 16 grams was removed, it pre-
sen ted the h i s t o l o g i c changes o f n o d u l a r 
adrenal hyperplasia. The postoperat ive ur i -
nary 17 hydroxysteroid level was 4.6 mg per 
day but the patient short ly developed symp-
toms of steroid insuff ic iency and required 
ful l steroid replacement therapy for over sev-
en years. Thereafter she developed hyper-
tens ion, and when dermal atrophy was also 
noted replacement therapy was discon-
t inued. By 1963 she had dist inct features of 
Cush ing 's disease and the recu r rence was 
subs tan t ia ted by l abo ra to ry i nves t i ga t i on . 
Basal 17 hydroxysteroids and 17 ketosteroids 
were 37.3 and 26.9 mg per day, rising to 56.2 
and 26.5 w i th ACTH. Use of 2 mg per day of 
dexamethasone caused no suppression, but 
urinary 17 hydroxysteroids fell to 8.4 mg per 
day w i th use of 8 mg of dexamethasone. The 
le f t ad rena l r e m n a n t was r e m o v e d . It 
w e i g h e d e i gh t g rams and a lso s h o w e d 
nodular cortical hyperplasia. Clinical remis-
sion was again achieved. 
Case # 5 . This p a t i e n t was 25 years o l d 
when the diagnosis of Cushing's disease was 
made in 1968 and a total bilateral adrenalec-
tomy was per formed elsewhere. Under treat-
ment elsewhere, she was given fu l l replace-
ment doses o f cort isone daily over the next 
year. She first presented at Henry Ford Hospi-
tal in 1969 wi th severe psychiatric symptoms 
and f lor id signs of Cushing's disease. Cor-
t isone was d iscont inued and the plasma Cor-
tisol was greater than 40 mcg% in the morn -
i n g , w i t h a f t e r n o o n values o f 35 m c g % . 
Basal urinary 17 hydroxysteroids of 16.5 mg 
per day rose to 51.3 mg w i th ACTH and fell 
t o 12.5 m g per day w h e n us i ng 8 mg o f 
dexamethasone a day. She was treated w i th 
psychot rop ic drugs and 5,000 roentgens to 
the p i tu i tary . Five mon ths later her cl inical 
status was improved, ur inary 17 hydroxy-
s te ro ids w e r e 9.7 m g per day and the A M 
p lasma Cor t i so l was 14 m e g . The p a t i e n t 
r e m a i n e d a m e n o r r h e i c and e m o t i o n a l l y 
unstable, however, and w i th in a few months 
the level o f plasma Cortisol increased to 22.6 
mcg%. Treatment w i th or tho-para ' DDD was 
init iated and after five months of t reatment 
a comp le te remiss ion o c c u r r e d . W i t h i n six 
mon ths the b lood pressure again rose, the 
pat ient gained we igh t and no ted increased 
b ru i s i ng . P igmenta t ion increased a l though 
the sku l l x-ray was n o r m a l . Plasma Cortisol 
exceeded 20 mcg% wi thou t diurnal change. 
Because she re fuses f u r t h e r su rge ry t h e 
patient is maintained w i th or tho-para ' D D D 
3 gm daily along w i th 10 mg of hydrocor-
t isone and is asymptomatic. 
Case # 6 . This pa t ien t was 43 w h e n f i rs t 
seen for evaluation of Cushing's syndrome in 
1967. 17 hydroxysteroids were 87 mg per day 
and 17 ketosteroids 16.3 mg per day. There 
was no suppression w i th dexamethasone or 
s t i m u l a t i o n by A C T H . An a d e n o m a was 
removed a n d , a l though the pa tho logy was 
suggestive of carc inoma, the lesion appeared 
to be en t i re l y encapsu la ted . F u r t h e r m o r e , 
t h e n o r m a l u r i na r y 17 k e t o s t e r o i d leve ls , 
character is t ic for a d e n o m a , suppo r ted the 
impression of a benign lesion. Steroids were 
d i scon t i nued af ter a s i x -mon th pe r iod and 
the patient experienced no fur ther d i f f icu l ty 
u n t i l t h e C u s h i n g ' s s y n d r o m e r e c u r r e d 
almost two years after the original surgery. 
Pulmonary metastases were present and the 
pa t ien t was t rea ted w i t h o r t h o para ' D D D 
and rad ia t i on . He responded t e m p o r a r i l y , 
b u t t h e n g radua l l y d e t e r i o r a t e d and d i e d 
despite extensive chemotherapy. 
Case # 7 . This 26-year-old mo the r of one 
chi ld developed Cushing's syndrome in 1961 
w i t h l a b o r a t o r y data c h a r a c t e r i s t i c o f 
a d r e n o c o r t i c a l h y p e r p l a s i a . W h e n 4,000 
roentgens of cobalt teletherapy to the p i tu i -
tary gland failed to produce any evidence of 
remission, bilateral total adrenalectomy was 
per formed and revealed adenomatous hyper-
plasia o f bo th g lands. C o m p l e t e remiss ion 
o c c u r r e d and the pa t ien t was successfu l ly 
d e l i v e r e d o f her s e c o n d c h i l d 18 m o n t h s 
later. Steroid therapy in the fo rm of 20 mg 
h y d r o c o r t i s o n e and i n t e r m i t t e n t 9 a lpha 
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f lurohydrocort isone was cont inued unti l 
March, 1972. At that time persistent edema, 
headache and weight gain led to discontinua-
tion of hormone therapy. Progressively rising 
plasma and urinary Cortisol levels were 
recorded over the next six months. Radioac-
tive iodocholesterol scanning* demonstrated 
the presence of recurrent tissue in the left 
adrenal bed and the nodular hyperplastic 
remnant was removed with a resultant cure. 
Progressive pigmentation has occurred in 
subsequent months. 
T A B L E IV 
COMPLICATIONS 
Dermal Pigmentation 10 
Intense 5 
Moderate 5 
Hyperpigmentation with Sella Enlargement 1 
Psychosis after Adrenalectomy 5 
Hyperthyroidism Two Months after 
Adrenalectomy i 
Pseudotumor Cerebri 1 
Additional Complications 
As shown in Table IV, 10 patients wi th 
adrenal hyperplasia became pigmented 
after t reatment . O n e of these patients 
died suddenly wi th hemorrhage into a 
p i t u i t a r y a d e n o m a 11 years a f te r 
a d r e n a l e c t o m y . The sel la was no t 
e n l a r g e d . O n e pa t ien t d e v e l o p e d an 
enlargement of the sella turcica fo l low-
ing adrenalectomy. This was associated 
w i t h m o d e r a t e sk in p i g m e n t a t i o n , 
hypothyroidism and low growth hor-
mone levels wh ich were unresponsive 
to insu l in - induced hypog lycemia. She 
was treated subsequently wi th pituitary 
irradiat ion. 
T A B L E V 
C A N C E R IN CUSHING'S SYNDROME 
Para Endocrine Syndrome 
Lung Cancer and Thyroid Cancer 1 
Neuroblastoma 1 
Medullary Thyroid Cancer and 
Pheochromocytoma 1 
Adrenal Cancers 4 
Occurring During or after Hypercorticism 
Endometrial Cancers 3 
Rectal Cancer 1 
Thyroid Cancer 1 
Adenocarcinoma of the Mandible 1 
TOTAL 13 
Five patients had psychiatric problems 
of a magnitude severe enough to neces-
sitate hospi ta l izat ion. Hyper thyro id ism 
o c c u r r e d in one pa t ien t t w o m o n t h s 
after adrenalectomy and pseudotumor 
cerebri developed in a n o t h e r pa t i en t 
whi le his adrenal disease was active. 
Wi th the exception of ACTH produc-
ing neoplasms an increased inc idence 
of n o n - a d r e n a l cancer has no t been 
reported in Cushing's syndrome. In our 
series, however, there were 13 patients 
wi th malignant disease (Table V). Four 
'Performed in cooperation with Drs. Martin 
E. Sturman and William H. Bierewaltes, Divi-
sion of Nuclear Medicine, University of 
Michigan, Medical Center, Ann Arbor, 
Michigan. 
malignancies were func t ion ing adrenal 
carcinomas. Three patients were felt to 
have malignancies secreting ACTH. One 
of these had ca rc i noma of t he l u n g , 
b i la te ra l adrena l hyperp las ia and an 
occult thyroid cancer noted at autopsy. 
A chi ld w i th bilateral adrenal hyper-
plasia, successfully treated wi th bilateral 
adrenalectomy, died four year later wi th 
a central nervous system neuroblas-
toma. The th i rd patient died at the t ime 
of her a d r e n a l e c t o m y . A p rev i ous l y 
unsuspected phenochromocy toma and 
medullary thyroid cancer were found at 
autopsy. 
Six addit ional patients developed car-
c inomas f o l l o w i n g t he rapy . Three of 
these were endometr ial cancers diag-
nosed t w o , e igh t and ten years af ter 
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T A B L E VI 
DEATHS 
Number Ages 
1. Endocrine Related (10) 
Adrenal Carcinoma 
Ectopic ACTH 
Addisonian Crisis 
Pituitary Apoplexy 
Untreated Cushing's Disease 
II. Other (2) 
Renal Failure and Diabetes 
Fractured Leg with Fat Emboli 
16, 46. 29, 45 
10, 59, 46 
40 
27 
2 mo. 
61 
81 
TOTAL 12 
t r e a t m e n t . O n e pa t i en t had recta l 
cancer and another a mixed papillary-
fol l icular thyroid cancer two years after 
ad rena lec tomy . O n e pa t ien t w i t h an 
adrena l adenoma d e v e l o p e d an 
a d e n o c a r c i n o m a of t he m a n d i b l e 17 
years a f te r adrena l su rge ry . Two 
pa t ien ts had p i t u i t a r y t u m o r s af ter 
removal of hyperplastic adrenals. 
Table VI lists the 12 deaths which 
occu r red in this g roup of 52 pat ients . 
Ten deaths were directly related to the 
endoc r i ne d i s tu rbance . Eour pat ients 
d i ed f r o m c a r c i n o m a . Three o t h e r 
patients died wi th cancers known to be 
associated w i th the ectopic ACTH syn-
drome. One patient died at home three 
m o n t h s a f te r su rgery p r o b a b l y of 
adrenal insuff iciency. One chi ld died at 
the age of two months, before def ini t ive 
therapy cou ld be in i t ia ted . This c h i l d , 
born wi th Cushing's disease, has been 
reported previously." 
O n e pat ient d ied 11 years after her 
Cushing's disease had been treated by 
bi lateral adrena lec tomy. A l t hough she 
had noted progressive hyperpigmenta-
t i o n s ince t r e a t m e n t , sel la t u r c i ca 
enlargement did not appear for 11 years 
and she had d e l i v e r e d t w o no rma l 
babies whi le on replacement therapy. A 
ch romophobe adenoma was subtotal ly 
removed w h e n increased in t racrania l 
pressure developed rapidly. The patient 
responded well postoperatively only to 
deve lop fatal c a r d i o p u l m o n a r y arrest 
the n igh t af ter surgery . O n e d iabet ic 
pa t i en t d i ed w i t h renal f a i l u re m o r e 
than 20 years after adrena lec tomy and 
another had a pu lmonary fat embo lus 
after a hip fracture. 
Discussion 
Results of our treatment are in keep-
ing w i t h p rev ious repor ts . Un i la te ra l 
ad rena lec tomy for a so l i ta ry adrena l 
adenoma was curative in all patients so 
treated and all patients wi th adrenal car-
cinoma eventually died of their disease. 
External pituitary radiation was success-
fu l in 6 of 14 pat ien ts w i t h b i la te ra l 
hyperp las ia . Radiat ion and un i la tera l 
a d r e n a l e c t o m y t o g e t h e r or sub to ta l 
a d r e n a l e c t o m y w e r e successfu l in a 
smaller number of patients. Our results 
wi th radiation are comparable to those 
reported by others. 
A l t h o u g h Croughs and Docter have 
reported beneficial immediate effect of 
p i t u i t a r y rad ia t i on and un i l a te ra l 
adrenalectomy, this procedure has been 
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abandoned in our practice, as long term 
resul ts are no be t t e r than e i t h e r 
ad rena lec tomy or p i t u i t a ry rad ia t i on 
a l o n e . O r i g i n a l l y this p rocedure was 
also per formed to conf i rm the adrenal 
pathology, but it is no longer necessary 
wi th current diagnostic procedures. 
Total adrenalectomy was also curative 
a l though there were t w o recurrences. 
Siegal and co-workers and Schteingart's 
g roup also repo r ted recur rence after 
to ta l a d r e n a l e c t o m y . W h e t h e r th is 
rare c o m p l i c a t i o n may resu l t f r o m 
adrenal remnants left inadver tent ly at 
the t ime of surgery or whether ectopic 
adrenal tissue is present and activated 
by prolonged and intensive ACTH pro-
duct ion may be di f f icul t to determine. 
The use of o r t h o para ' D D D as an 
a d r e n o t o x i c chemica l su i tab le fo r 
therapy has made c la r i f i ca t ion of the 
p r o b l e m less c r u c i a l . H o w e v e r , 
i o d o c h o l e s t e r o l scann ing in such 
patients may aid in precise localization 
of adrenal tissue, making repeat cura-
tive surgery possible. 
Recur rences a f te r a s y m p t o m a t i c 
per iods last ing f r om one to ten years 
appeared f o l l o w i n g all moda l i t i es o f 
therapy, but were more common after 
subto ta l ad rena lec tomy . In the series 
reported by We lbourn , recurrence was 
also m o r e f r e q u e n t a f te r sub - to ta l 
adrenalectomy.^^ 
deeply p i gmen ted , bu t x-rays had not 
demonstrated sella turcica enlargement 
unti l 11 years after her adrenal surgery. 
Unfortunately, little data is available to 
document radiation effectiveness in this 
pituitary disorder. Or th reports no cases 
of Nelson's syndrome in patients pre-
v ious l y t r ea ted w i t h p i t u i t a r y 
i r rad ia t ion .^^ H o w e v e r , o u r pa t i en t 
(Case #2) had two courses of radiat ion, 
one of which produced a remission in 
her Cushing's disease, only to develop 
in tense p i g m e n t a t i o n f o l l o w i n g her 
even tua l a d r e n a l e c t o m y . A l t h o u g h 
rad ia t ion may he lp p reven t Ne lson 's 
syndrome, it apparently wi l l not prevent 
the disorder in all patients wi th adrenal 
hyperplasia. 
I n t e r m i t t e n t A d d i s o n ' s disease 
(pat ient in Case #3) a l t e rna t ing w i t h 
Cushing's disease is a rare compl icat ion 
of subtotal adrenalectomy. In reviewing 
this phenomenon, Egdah has suggested 
that the adrenal remnant may undergo 
f luctuat ing steriod p roduc t ion , making 
contro l d i f f icul t . ' " 
A large n u m b e r of ou r pa t ien ts 
developed serious complications dur ing 
an e x t e n d e d p e r i o d of o b s e r v a t i o n . 
These comp l i ca t ions , after t rea tment , 
seem directly related to Cushing's syn-
d r o m e . Several pa t ien ts d e v e l o p e d 
medical problems not usually associated 
wi th endocr ine disorders. 
Our approach to therapy in patients 
w i th bi lateral adrenal hyperplasia is as 
fo l lows: a) pituitary radiation in patients 
wi th mild disease in whom an expected 
p e r i o d of o b s e r v a t i o n w i l l n o t be 
assoc ia ted w i t h d e t e r i o r a t i o n in t h e 
pa t ien t ' s c o n d i t i o n ; o r b) to ta l 
ad rena lec tomy in pat ients w i t h mo re 
aggressive disease. In addi t ion, pituitary 
radiation probably should be adminis-
tered to patients w i th progressive hyper-
pigmentat ion. The patient in Case # 7 
had received no radiotherapy. She was 
The f inding of 13 cases of malignancy 
in our group has not characterized the 
pat ients in o ther series. In 1952, Plotz 
reported the cause of death in 114 cases 
of Cush ing 's synd rome and rev iewed 
the existing l iterature to that t ime. He 
found six tumors of the thymus, four of 
the pancreas and one sympathicoblas-
toma . Excluding those w i t h adrenal or 
p i tu i ta ry t u m o r s , 10% of pat ients had 
neoplasms. Most of these cases were 
probably examples of the ectopic ACTH 
s y n d r o m e . In the series r e p o r t e d by 
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Welbourn , no note is made of non-
e n d o c r i n e neop las ia except fo r one 
pa t ien t w h o d i ed w i t h cancer of t h e 
cecum. A l t hough f i nd i ng of increased 
malignancy may be due to chance var-
ia t ion , the three cases of endomet r ia l 
cancer in 39 females are of i n te res t . 
Even though association between Cush-
ing's syndrome and neoplasia must be 
conjectural , it has been postulated that 
mal ignancy may be associated w i t h a 
deficient immunological state. Con-
ceivably, high levels of cor t icosteroids 
interfere wi th the normal immunolog i -
cal mechanics which retard a tendency 
to develop neoplasm.'= 
Desp i te the gene ra l l y sa t is fac tory 
prognos is fo r pat ients w i t h Cushing 's 
d isease, ser ious c o m p l i c a t i o n s may 
arise. Even patients successfully treated 
for the d iso rder appear to be at h igh 
risk and need cont inued observat ion. 
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